Legal Opinion of Shanghai AllBright Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Nanmo Biology: Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement on the Resignation of Non-Independent Directors and the By-election of Non-Independent Directors
Constitution of Shanghai Southern Model Biotechnology Co., Ltd. (Revised in September 2024)
Announcement on increasing the scope of business of the company and revising the “Articles of Association”
Nanmo Biotech: Announcement on the repurchase of the company\'s shares to reach 3% of the total share capital through centralized bidding transactions and the implementation results of the share repurchase
Shareholders\' inquiries and indicative notice on transfer pricing
Shareholders\' inquiry and transfer plan
Shanghai Model Organisms Center, Inc.: Announcement on the shareholder holdings of the top ten shareholders and the top ten unrestricted shareholders regarding share repurchase matters.
Shanghai Model Organisms Center, Inc.: Announcement Regarding the Company's First Stock Repurchase through Centralized Competitive Trading Method.
Announcement of Resignation of Vice General Manager and CFO
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Shanghai AllBright Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
Materials of the 2023 Annual General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
2024 “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Notice on convening the 2023 Annual General Meeting of Shareholders
Non-operating capital occupation and other related capital transactions
No Data
No Data